Gastric Cancer, Gastroesophageal Junction Cancer Clinical Trial
Official title:
Evaluation of HER-2 Status in Gastric and Gastro-Oesophageal Junction Carcinoma.
The objective of this study is to assess concordance between two different laboratory methods for determination of human epidermal growth factor receptor 2 (HER-2) status in participants with gastric and gastro-esophageal junction carcinomas in routine practice compared to centralized analysis. Immunohistochemistry (IHC) and in situ hybridization (ISH) methods are compared in this study.
n/a
Observational Model: Case-Only, Time Perspective: Cross-Sectional